COMTEX SCIENTIFIC CORPORATION – Trademark Portfolio
Entity Type: 03
COMTEX SCIENTIFIC CORPORATION holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include COMTEX and CUSTOMWIRE. The owner is based in NEW YORK, NY.
850 THIRD AVENUE
NEW YORK, NY 10022
Showing of trademarks Trademarks
Trademark Classifications
COMTEX SCIENTIFIC CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does COMTEX SCIENTIFIC CORPORATION have?
COMTEX SCIENTIFIC CORPORATION has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 4 cancelled.
What trademark classes does COMTEX SCIENTIFIC CORPORATION file in?
COMTEX SCIENTIFIC CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are COMTEX SCIENTIFIC CORPORATION's most well-known trademarks?
COMTEX SCIENTIFIC CORPORATION's registered trademark portfolio includes well-known marks such as COMTEX and CUSTOMWIRE. These are among 2 currently registered trademarks in the portfolio.
What is COMTEX SCIENTIFIC CORPORATION's trademark registration success rate?
COMTEX SCIENTIFIC CORPORATION has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.